AKI studies reveal WTAP, METTL3, and FTO as mediators of oxidative stress and inflammation through gene expression modulation, suggesting druggable targets (Wang et al., 2022; Lan et al., 2022; Chen et al., 2023). This evidence concerns the gene WTAP and acute kidney injury.